SCA has made a binding offer to acquire the Taiwan-based hygiene products company Everbeauty. The purchase price for the deal amounts to approximately SEK 1.9bn (USD 290m) on a debt-free basis. If the deal is realized, SCA’s positions in Asia, one of the Group’s prioritized growth markets, will be substantially strengthened.
Everbeauty is a leading Asian personal care products company with sales in China, Taiwan and Southeast Asia. The company produces and markets baby diapers and incontinence care products with strong brands such as Dr P for incontinence care products and Sealer for baby diapers.
Within incontinence care products, the company holds a number two position in China and a number one position in Taiwan. Within baby diapers, the company holds a number five position in China and Taiwan.
Everbeauty had sales of SEK 1.6bn in 2010. 60 percent of sales are related to baby diapers and 40 percent comes from incontinence care products. The company has around 900 employees.
The transaction is expected to give SCA access to an extensive distribution network and a strong sales organization as well as production facilities in China and Taiwan.
This proposal is subject to Everbeauty being privatized under Taiwanese law. Completion of the transaction remains subject to certain conditions, including approvals and clearances by relevant authorities in Taiwan. Closing of the deal is expected to take place in the summer of 2012.
“Asia is expected to account for 60 percent of the global growth within hygiene products. The acquisition of Everbeauty would create good growth opportunities in a strategic growth market and with this acquisition, SCA would be the market leader in incontinence care products in Asia, excluding Japan. The acquisition would also strengthen SCA´s market position and geographical reach within baby diapers in Asia”, says Jan Johansson, SCA’s President and CEO.
Today, SCA is present in Asia with personal care and tissue products and on some markets holds leading positions. SCA also holds an 18 percent ownership in Vinda International, one of the leading tissue producers in China.
Stockholm, Sweden, 25 February 2012
For additional information, please contact:
Pär Altan, Vice President Media Relations, +46 8 788 5237
Johan Karlsson, Vice President Investor Relations, +46 8 788 5130
NB: This information is such that SCA must disclose in accordance with the Securities Markets Act and/or the Financial Instruments Trading Act. The information was submitted for publication on February 25, 2012, at 08.00 CET.
Attached file: wkr0001.pdf